Back
Cosmo Pharmaceuticals NV Vs. Nebius Group NV Industry Stock Comparison
Sell
34
CMOPF
Cosmo Pharmaceuticals NV
Last Price:
$109.00
Seasonality Move:
-11.15%
Buy
51
NBIS
Nebius Group NV
Last Price:
$108.86
Seasonality Move:
16.36%
Sell
34
Cosmo Pharmaceuticals NV (CMOPF)
is a Sell
Is Cosmo Pharmaceuticals NV a Buy, Sell or Hold?
-
The current Cosmo Pharmaceuticals NV [CMOPF] share price is $109.00. The Score for CMOPF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CMOPF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
Nebius Group NV (NBIS)
is a Buy
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $108.82. The Score for NBIS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
NBIS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CMOPF Stock Price Chart
What is Cosmo Pharmaceuticals NV's stock price today?
-
The Cosmo Pharmaceuticals NV share price today is $109.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CMOPF is experiencing selling pressure, which indicates risk of future bearish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $108.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
CMOPF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 23.41 | Buy |
| Relative Strength Index (14 RSI): | 44.1 | Sell |
| Chaikin Money Flow: | -555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.47 - 132.91) | Sell |
| Bollinger Bands (100): | (97.71 - 149.33) | Sell |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1 | Buy |
| Relative Strength Index (14 RSI): | 52.24 | Buy |
| Chaikin Money Flow: | 13258215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.12 - 116.9) | Buy |
| Bollinger Bands (100): | (86.58 - 107.22) | Buy |
CMOPF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 102.98 | Buy |
| 20-day SMA: | 108.64 | Buy |
| 50-day SMA: | 134.23 | Sell |
| 200-day SMA: | 99.21 | Buy |
| 8-day EMA: | 102.78 | Buy |
| 20-day EMA: | 82.86 | Buy |
| 50-day EMA: | 49.07 | Buy |
| 200-day EMA: | 15.36 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.45 | Buy |
| 20-day SMA: | 108.76 | Buy |
| 50-day SMA: | 99.99 | Buy |
| 200-day SMA: | 89.14 | Buy |
| 8-day EMA: | 105.76 | Buy |
| 20-day EMA: | 106.36 | Buy |
| 50-day EMA: | 102.68 | Buy |
| 200-day EMA: | 86.85 | Buy |
Cosmo Pharmaceuticals NV Earnings Growth & CMOPF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.82 per share, a decrease this year of $0.72 per share, and an increase next year of $1.68 per share.
Cosmo Pharmaceuticals NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||